20/20 GeneSystems, Inc. announced a private placement of minimum 9,364 preferred stock and maximum of 936,329 preferred stock at a price of $5.34 per share for minimum gross proceeds of $50,000 and maximum gross proceeds of $5,000,000 on May 6, 2024. The company is raising funding through crowd-funding platform Wefunder Portal LLC. The company will pay fees of 7.9% of the offering amount upon a successful fundraise, and be entitled to reimbursement for out-of-pocket third party expenses it pays or incurs on behalf of the Issuer in connection with the offering.

The company will accept oversubscription on the basis of determined by the issuer. The round has raised at a pre money valuation of $7,920,000. The company will issue securities pursuant to exemptions provided under Regulation C. The transaction is expected to close on April 30, 2025.

The securities are subject to restriction of transfer for a period of one year from issuance.